Below you will find a list of past seminars. Seminars that were recorded are available via video below and on our YouTube Playlist as part of NCI YouTube.
2022 Seminars
December 1 Mathais Heikenwälder, PhD, Professor, German Cancer Research Center, Germany
November 17 Sanford Simon, PhD,The Gunter Blobel Professor, The Rockefeller University, NY
October 17 Bruno Sangro, MD,Professor, University of Navarra, Spain
September 22 Augusto Villanueva, MD, PhD, Associate Professor, Mount Sinai
June 13 Jessica Zucman-Rossi MD, PhD, Professor, University Paris Descartes, France
Mechanisms of Liver Carcinogenesis Across a Lifetime
May 19 Robert Schwabe, MD, PhD Professor, Columbia University
The Role of Hepatic Stellate Cells in Liver Cancer
April 28 Josep M. Llovet, MD, Professor, Mount Sinai, NY and University or Barcelona, Spain
March 31 Ignacio Melero Bermejo, MD, PhD, Professor, University of Navarra, Spain
New Waves of CD137(4-1BB) Based Immunotherapies
February 15 Helen Reeves, MD, PhD, Professor, Newcastle University, UK
January 13 Mark Yarchoan, MD, Assistant Professor, Johns Hopkins University
2021 Seminars
December 6 Zemin Zhang, PhD, Professor, Peking University
Single Cell Analysis of Tumor Infiltrating Immune Cells in Liver Cancer and Beyond
November 18 Bin Gao, MD, PhD, Chief, Laboratory of Liver Diseases, NIAAA, NIH
October 21 Bernd Schnabl, MD, Professor, University of California at San Diego
Nonbacterial Kingdoms of the Gut Microbiota and Liver Disease
September 30 Eli Pikarsky, MD, PhD, Associate Professor, The Hebrew University of Jerusalem
Pro and Anti Tumor Functions of Tertiary Lymphatic Structures in the Liver
June 21 Jesper Andersen, MSc, PhD, Associate Professor, University of Copenhagen
June 7 Shalev Itzkovitz, PhD, Associate Professor, Weizmann Institute of Science
June 3 Lewis Roberts, MB, ChB, PhD, Professor, Mayo Clinic
May 20 Hao Zhu, MD, Associate Professor, Children's Research Institute, UT Southwestern Medical Center
April 23 Bernadette Redd, MD, Lead Radiologist Body MRI, Radiology and Imaging Sciences, NIH Clinical Center
March 25 Jill Koshiol, PhD, Senior Investigator, Division of Cancer Epidemiology and Genetics, NCI
February 26 Xin Wei Wang, PhD, Co-Director, NCI CCR Liver Cancer Program
Defining Liver Cancer Heterogeneity – New Challenges and Opportunities (CCR Grand Rounds)
February 18 Satdarshan (Paul) Singh Monga, MD, FAASLD, Vice Chair and Chief, Division of Experimental Pathology, University of Pittsburg
Targeting Metabolic and Cellular Reprogramming for Precision Medicine in Hepatobiliary Tumors
January 28 Freddy Escorcia, MD, PhD, Physician-Scientist Early Investigator, Molecular Imaging Branch
2020 Seminars
Barbara Rehermann, M.D., Chief, Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH
Regulation of immunity in the era of successful antiviral therapy against hepatitis C Thursday, December 10, 2020, 2:00PM
Ludmila Prokunina-Olsson, Ph.D., Chief and Senior Investigator and Olusegun Onabajo, Ph.D., Staff Scientist
Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI
The role of IFNL4 in liver disease: why and how? Thursday, November 19, 2020, 2:00 PM
Anuradha Budhu, Ph.D. Program Manager, Liver Cancer Program, and Senior Associate Scientist, NCI
Multi-omics Applications in Human Liver Cancer Friday, June 5, 2020, 12:00PM
2019 Seminars
Yujin Hoshida, M.D., Ph.D., Director, Liver Tumor Translational Research Program, University of Texas Southwestern Medical Center
Molecular HCC Risk Prediction and Chemoprevention
Thursday, November 14, 2019, 2:00PM, NIH Campus - Building 37 - Room 6041/6107
Amaia Lujambio, Ph.D., Assistant Professor, Icahn School of Medicine at Mount Sinai
Novel Precision Mouse Models for Liver Cancer
Thursday, September 12, 2019, 2:00PM, NIH Campus - Building 37 - Room 6041/6107
Junfang Ji, Ph.D., Professor, Life Sciences Institute, Zhejiang University
Loss of miR-192 Fueled Cancer Stem Cells with an Enhanced Glycolysis in Hepatocellular Carcinoma
Wednesday, July 10, 2019, 1:00PM, NIH Campus - Building 37 - Room 2041/2107
Radoslav Goldman, Ph.D., Professor, Department of Oncology, Georgetown University
Quantitative Glycoproteomics of Liver Disease and HCC
Thursday, May 16, 2019, 1:00PM, NIH Campus - Building 37 - Room 2041/2107
Stephanie Roessler, Ph.D., Research Group Leader, Heidelberg University Hospital, Institute of Pathology
The Role of NOTCH/HES5 Signaling in Liver Cancer Development
Wednesday, March 27, 2019, 1:00PM, NIH Campus - Building 37 - Room 2041/2107
Amanda Craig, Ph.D., Postdoctoral Fellow, Icahn School of Medicine at Mount Sinai
Molecular Heterogeneity and Drivers of Liver Cancer Evolution
Wednesday, January 23, 2019, 1:00PM, NIH Campus - Building 37 - Room 2041/2107
2018 Seminars
Jens Marquardt, M.D., is Lichtenberg Professor for Molecular Carcinogenesis and Group Leader and Physician, Department of Internal Medicine at the University of Mainz, Germany
Patient-derived Models to Dissect Molecular Mechanisms of Chemoresistance in Human Liver Cancer
Thursday, November 8, 2018,10:00 - 11:00 AM, NIH Campus - Building 37 - Room 2041/2107
Junfang Ji, Ph.D., Professor, Life Sciences Institute, Zhejiang University, China
The Role of miR-192-5p Silencing in Hepatocellular Carcinomas With Cancer Stem Cell Features
Wednesday, July 18, 2018, 1:00 - 2:00 PM, NIH Campus - Building 37 - Room 2041/2107
Liqin Zhu, Ph.D., Assistant Member, Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
Modeling Advanced Liver Cancer Development and Heterogeneity Using Organoids
Tuesday, July 10, 2018, 4:00 - 5:00 PM, NIH Campus - Building 37 - Room 2041/2107
Taro Yamashita, M.D., Ph.D., Associate Professor, Department of General Medicine, Kanazawa University Hospital
Reversal of Liver Cancer Progression from Preneoplastic Lesions
Department of System Biology, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanzawa, Japan
Monday, June 4, 2018, 10:00 - 11:00 AM, NIH Campus - Building 37 - Room 4021/4041